BioAge Labs, Inc.
BIOANASDAQHealthcare● Active
$15.51
$-0.19(-1.21%)
Market Cap$583945839
P/E Ratio—
52W High$24
52W Low$4.065
BioAge Labs, Inc.（BIOA）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · BIOA · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 |
|---|---|---|---|---|
| Revenue | ||||
| Revenue | $8.99M | $0.00M | $0.00M | $0.00M |
| Cost of Revenue | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Profit | $8.99M | $0.00M | $0.00M | $0.00M |
| Gross Margin %(computed) | 100.00% | — | — | — |
| Operating Expenses | ||||
| R&D Expenses | $73.97M | $59.04M | $33.89M | $30.52M |
| G&A Expenses | $27.81M | $19.16M | $14.51M | $9.45M |
| Total Operating Expenses | $101.78M | $78.19M | $48.40M | $39.97M |
| Operating Income | ($92.78M) | ($78.19M) | ($48.40M) | ($39.97M) |
| Operating Margin %(computed) | — | — | — | — |
| Interest Income | $13.09M | $9.63M | $2.43M | $0.47M |
| Interest Expense | $0.70M | $2.37M | $7.79M | $0.24M |
| Income Before Tax | ($80.61M) | ($71.11M) | ($63.85M) | ($39.72M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($80.61M) | ($71.11M) | ($63.85M) | ($39.72M) |
| Net Margin %(computed) | -896.11% | — | — | — |
| Per Share & EBITDA | ||||
| EPS (Basic) | $-2.24 | $-1.98 | $-1.87 | $-1.16 |
| Wtd Avg Shares | 35.93M | 35.85M | 34.20M | 34.17M |
| EBITDA | ($79.69M) | ($68.58M) | ($55.90M) | ($39.35M) |
| EBITDA Margin %(computed) | -885.99% | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解BioAge Labs, Inc.
关于BioAge Labs, Inc.（BIOA）损益表
BioAge Labs, Inc.（BIOA）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，BIOA实现营收$0.01B，毛利润$0.01B（毛利率100.00%），净利润($0.08B)（净利率-896.11%）。
常见问题
BIOA · 4 问BioAge Labs, Inc.（BIOA）2025财年营收为$0.01B，同比up—%。
BIOA revenueBIOA salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09